Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2008) 16 P741

ECE2008 Poster Presentations Thyroid (146 abstracts)

Pharmacokinetics of digoxin in hyperthyroidism: effect of methimazole and acebutolol

Teresa Gasinska 1 , Maria Izbicka 1 & Renata Dec 2


1Department of Internal Diseases, Silesian Medical University, Katowice, Poland; 2Department of Nuclear Medicine, Silesian Medical University, Katowice, Poland.


Hyperthyroid patients show an impaired response or even resistance to digoxin treatment.

Objectives: 1. Are there any differences in the pharmacokinetics of a single oral dose of digoxin between hyperthyroid and euthyroid patients? 2. Does simultaneous administration of digoxin and methimazole or digoxin and acebutolol affect the pharmacokinetics of a single oral dose of dogoxin? 3. Does methimazole-induced euthyroidism change the pharmacokinetics of a single oral dose of digoxin? 4. Does acebutolol, which ameliorates symptoms of hyperkinetic circulation change the pharmacokinetics of a single oral dose of dogoxin?

Design and method: The subject of the study were 28 patients with hyperthyroidism and 15 healthy persons.We evaluated the pharmacokinetics of a single oral dose of digoxin. Twelve methimazole treated patients were re-assessed once they had become euthyroid. Sixteen acebutolol-treated patients were re-asessed once symptoms of hyperkinetic circulation had subsided.Moreover we evaluated pharmacokinetics of a single dose of digoxin after simultaneous administration of digoxin and methimazole or digoxin and acebutolol.

Results: Hyperthyroid patients showed significantly lower serum digoxin concentrations, shorter T½ beta and a significantly smaller area under the concentration curve that the control group. Administration of methimazole did not affect digoxin pharma-co-kinetics, administration of acebutolol resulted in an increased serum digoxin concentration and in a longer time to the peak serum level of digoxin in comparison with the control group.

Conclusions: In hyperthyroid patients the pharmacokinetics of a single oral dose of digoxin does differ from that observed in healthy subjects. Acebutolol but not methimazole do alter digoxin pharmacokinetics in hyperthyroid patients.

Article tools

My recent searches

No recent searches.